Under Therapeutic Goods Administration (TGA) regulations, a medical device sponsor is the Australian-based party legally responsible for importing, exporting, or supplying a medical device in the local market. Understanding the TGA requirements for medical device sponsors is crucial for ensuring compliance throughout the product’s lifecycle.
Responsibilities for Initial Supply
Sponsors must ensure that each device is classified correctly according to the medical device risk-based model and included in the Australian Register of Therapeutic Goods (ARTG). This involves verifying conformity assessment procedures, maintaining clinical evidence, and meeting the essential principles for safety and performance. Sponsors must retain clear, accessible documentation supporting regulatory claims and be able to provide it upon request.
A working knowledge of the broader medical device TGA regulatory framework is essential to managing these processes effectively.

Post-Market and Ongoing Duties
TGA obligations do not end after ARTG inclusion. Sponsors must actively monitor product performance, investigate complaints, and report adverse events. Additional responsibilities may include updating labelling, managing corrective actions, and initiating product recalls when necessary.
Sponsorship Requires Total Lifecycle Commitment
Compliance with TGA requirements for medical device sponsors is not a one-time task but a continuous responsibility. Sponsors must stay informed, maintain detailed records, and demonstrate full oversight from initial supply through post-market surveillance. Fulfilling these duties is essential not only for regulatory approval but also for maintaining trust in the Australian medical device market.

